Search
Now showing items 1-6 of 6
Recent advances in Cancer treatment targeting autophagy and future aspects
(Brac University, 2022-03)
Lysosomal autophagy controls cellular homeostasis by degrading and recycling cytoplasmic molecules and organelles in the lysosome. This process in neuronal cells protects cognitive decline by removing abnormal intracellular ...
A review on potential of PARP inhibitors in the treatment of prostate cancer
(Brac University, 2022-05)
Prostate cancer is still a fatal disease at metastatic castration resistance stage (mCRPC) in spite of pursuing advancements in patient survival, indicating the necessity of therapeutic approaches. A significant number of ...
A review paper on Nanotechnology based strategies in the treatment of cancer
(Brac University, 2022-02)
Nanotechnology is a new discipline meeting the requirement for novel methods in cancer
treatment. Recently, cancer became very fatal condition that causes death worldwide. Hence,
traditional cancer treatment like ...
Precision medicine in four deadliest Cancers of the world : present practices & future prospects
(Brac University, 2022-02)
Cancer is a very personalized disease which is why conventional oncology treatment following the ‘one size fits all’ method is unable to cure all patients effectively and for this, cancer remains one of the leading causes ...
A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
(Brac University, 2022-06)
Nanoparticles have unique physicochemical and biological properties that make them one of the most promising candidate for targeted cancer therapy. Nanoparticle-based drug delivery has a number of advantages over conventional ...
CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
(Brac University, 2022-04)
The novel CRISPR/Cas system is an effective and widely used gene-editing tool that has created the opportunity to study gene function and understand the pathogenic mechanisms underlying various genetic disorders. It has ...